# AI for Digital Therapeutics

## Description

Use AI for Digital Therapeutics to personalize behavioral interventions and monitor patient adherence.

## When to use

You are building software-only, evidence-based interventions (prescription digital therapeutics) for mental health, substance use, sleep, ADHD, or chronic disease.


## Usage


- **Prescription digital therapeutics (PDTs)**: FDA-cleared software as a medical device requiring a prescription.
- **Software as a Medical Device (SaMD) and FDA 510(k)/De Novo pathways**.
- **Cognitive behavioral therapy (CBT)** and other behavioral interventions delivered via apps.
- **Real-time biometric feedback**: Smartwatch, smartphone sensors, and ecological momentary assessment.
- **Evidence and deployment**: RCTs, real-world evidence, reimbursement, and clinician dashboards.

## Steps

1. Collect and prepare app usage, sensor and patient-reported data.
2. Build software-only.
3. Evidence-based interventions (prescription digital therapeutics) for mental health.
4. Substance use.
5. Validate by analyzing app usage data to predict treatment adherence.
6. Deploy into the target workflow and monitor performance, drift, and outcomes.

## Code pattern

```python
import pandas as pd
from sklearn.ensemble import GradientBoostingClassifier

# Predict engagement or response from app usage and sensor data
X = df[['sessions_week', 'cbt_modules_completed', 'sleep_hours', 'heart_rate_variability']]
y = df['responder']

model = GradientBoostingClassifier().fit(X, y)
```


## Tuning notes

- Follow FDA/CE regulatory pathways and provide clinical evidence for intended claims.
- Design for engagement, adherence, and low dropout.
- Protect privacy and secure biometric and patient-reported data.
- Validate with randomized controlled trials and patient-reported outcomes.


## Verification

1. Analyze app usage data to predict treatment adherence.
2. Build a dashboard for clinicians to monitor patient progress.
3. Compare engagement and outcomes between the digital therapeutic and standard care.

## References

- https://www.healthaffairs.org/doi/10.1377/hlthaff.2024.00159
- https://www.frontiersin.org/journals/digital-health/articles/10.3389/fdgth.2023.1086219/full
- https://doi.org/10.1377/hlthaff.2023.00384
- https://doi.org/10.3390/pharmacy13010019
- https://accessgudid.nlm.nih.gov/devices/10851580008064
